Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II dose-finding study of TRD205 for chronic postoperative neuropathic pain
CTR20250577Phase 2Completed
- Sponsor
- Beijing Tide Pharmaceutical Co., Ltd.
- Start
- Apr 2025
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of TRD205 in Neuralgia, sponsored by Beijing Tide Pharmaceutical Co., Ltd.. Started Apr 2025; status: completed.
02
Drugs
TRD205
03
Conditions
Neuralgia
Beyond the preview
Go deeper on CTR20250577.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20250577.